Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NOS2 anticorps (AA 500-730)

NOS2 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN6144727
  • Antigène Voir toutes NOS2 Anticorps
    NOS2 (Nitric Oxide Synthase 2, Inducible (NOS2))
    Épitope
    • 16
    • 16
    • 13
    • 11
    • 8
    • 7
    • 6
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 500-730
    Reactivité
    • 108
    • 67
    • 67
    • 17
    • 2
    • 1
    Humain
    Hôte
    • 123
    • 12
    Lapin
    Clonalité
    • 118
    • 17
    Polyclonal
    Conjugué
    • 69
    • 14
    • 8
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp NOS2 est non-conjugé
    Application
    • 108
    • 41
    • 36
    • 32
    • 27
    • 26
    • 22
    • 18
    • 17
    • 16
    • 7
    • 4
    • 2
    Western Blotting (WB), Immunohistochemistry (IHC)
    Séquence
    VWQDEKRRPK RREIPLKVLV KAVLFACMLM RKTMASRVRV TILFATETGK SEALAWDLGA LFSCAFNPKV VCMDKYRLSC LEEERLLLVV TSTFGNGDCP GNGEKLKKSL FMLKELNNKF RYAVFGLGSS MYPRFCAFAH DIDQKLSHLG ASQLTPMGEG DELSGQEDAF RSWAVQTFKA ACETFDVRGK QHIQIPKLYT SNVTWDPHHY RLVQDSQPLD LSKALSSMHA K
     Réactivité croisée
    Humain, Souris, Rat
    Attributs du produit
    Polyclonal Antibodies
    Immunogène
    Recombinant fusion protein containing a sequence corresponding to amino acids 500-730 of human iNOS (NP_000616.3).
    Isotype
    IgG
    Top Product
    Discover our top product NOS2 Anticorps primaire
  • Indications d'application
    WB,1:500 - 1:2000,IHC,1:50 - 1:200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Qin, Yang, Huang, Du, Mai, Xiao, Lü: "Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia." dans: Pharmacological research, Vol. 133, pp. 218-235, (2018) (PubMed).

  • Antigène
    NOS2 (Nitric Oxide Synthase 2, Inducible (NOS2))
    Autre désignation
    NOS2 (NOS2 Produits)
    Synonymes
    anticorps HEP-NOS, anticorps INOS, anticorps NOS, anticorps NOS2A, anticorps NOS-II, anticorps Nos-2, anticorps Nos2a, anticorps i-NOS, anticorps iNOS, anticorps iNos, anticorps NOS2a, anticorps NOS2, anticorps BmNOS2, anticorps Nsl, anticorps nos2, anticorps nitric oxide synthase 2, anticorps nitric oxide synthase 2, inducible, anticorps inducible nitric oxide synthase, anticorps inducible nitric-oxide synthase, anticorps nanos C2HC-type zinc finger 2, anticorps NOS2, anticorps Nos2, anticorps nos2, anticorps LOC396821, anticorps NANOS2
    Sujet
    Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17.,NOS,INOS,NOS2A,HEP-NOS,iNOS,NOS2,Cancer,Endocrine & Metabolism,Insulin Receptor Signaling Pathway,Neuroscience,NOS2
    Poids moléculaire
    126 kDa/131 kDa
    ID gène
    4843
    UniProt
    P35228
    Pathways
    Retinoic Acid Receptor Signaling Pathway, Cellular Response to Molecule of Bacterial Origin, Inositol Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Vous êtes ici:
Support technique